ZA904583B - Leukotriene antagonists - Google Patents

Leukotriene antagonists

Info

Publication number
ZA904583B
ZA904583B ZA904583A ZA904583A ZA904583B ZA 904583 B ZA904583 B ZA 904583B ZA 904583 A ZA904583 A ZA 904583A ZA 904583 A ZA904583 A ZA 904583A ZA 904583 B ZA904583 B ZA 904583B
Authority
ZA
South Africa
Prior art keywords
alkoxy
alkyl
cor3
trifluoromethylthio
tetrazolyl
Prior art date
Application number
ZA904583A
Other languages
English (en)
Inventor
James Simpson Frazee
Simpson Frazee James
John Gerald Gleason
Gerald Gleason John
Ralph Floyd Hall
Floyd Hall Ralph
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of ZA904583B publication Critical patent/ZA904583B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/24—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00—Thiocarboxylic acids
    • C07C327/02—Monothiocarboxylic acids
    • C07C327/04—Monothiocarboxylic acids having carbon atoms of thiocarboxyl groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C327/08—Monothiocarboxylic acids having carbon atoms of thiocarboxyl groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of a saturated carbon skeleton containing rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • C07C317/46—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/56—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/62—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA904583A 1989-06-14 1990-06-13 Leukotriene antagonists ZA904583B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36604689A 1989-06-14 1989-06-14

Publications (1)

Publication Number Publication Date
ZA904583B true ZA904583B (en) 1992-05-27

Family

ID=23441449

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA904583A ZA904583B (en) 1989-06-14 1990-06-13 Leukotriene antagonists

Country Status (14)

Country Link
EP (1) EP0403249B1 (xx)
JP (1) JPH0324050A (xx)
KR (1) KR910000632A (xx)
AT (1) ATE104955T1 (xx)
AU (1) AU645253B2 (xx)
CA (1) CA2018437A1 (xx)
DE (1) DE69008428T2 (xx)
DK (1) DK0403249T3 (xx)
ES (1) ES2063271T3 (xx)
IE (1) IE902141A1 (xx)
MX (1) MX21139A (xx)
NZ (1) NZ234009A (xx)
PT (1) PT94373A (xx)
ZA (1) ZA904583B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5214201A (en) * 1991-12-12 1993-05-25 Smithkline Beecham Corporation Crystallization of optical isomers of leukotriene antagonists
WO1993017709A1 (en) * 1992-03-12 1993-09-16 Ono Pharmaceutical Co., Ltd. Antipruritic
CN1100092A (zh) * 1992-12-23 1995-03-15 史密丝克莱恩比彻姆公司 砜的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8700647A1 (es) * 1984-10-11 1986-11-16 Raychem Corp Procedimiento para la preparacion de un compuesto carbonilo aromatico
CA1334200C (en) * 1987-06-24 1995-01-31 James Simpson Frazee Leukotriene antagonists
AU610528B2 (en) * 1987-10-29 1991-05-23 Smithkline Beckman Corporation Leukotriene antagonists
JPH01153658A (ja) * 1987-12-08 1989-06-15 E R Squibb & Sons Inc ヘテロ含有置換基を有するフェニルヒドロキサム酸類
US4954513A (en) * 1988-12-23 1990-09-04 Smithkline Beecham Corporation Leukotriene antagonists

Also Published As

Publication number Publication date
ES2063271T3 (es) 1995-01-01
CA2018437A1 (en) 1990-12-14
IE902141A1 (en) 1991-01-02
DE69008428D1 (de) 1994-06-01
DE69008428T2 (de) 1994-11-24
EP0403249B1 (en) 1994-04-27
MX21139A (es) 1993-12-01
AU5690290A (en) 1990-12-20
KR910000632A (ko) 1991-01-29
ATE104955T1 (de) 1994-05-15
EP0403249A1 (en) 1990-12-19
IE902141L (en) 1990-12-14
JPH0324050A (ja) 1991-02-01
AU645253B2 (en) 1994-01-13
PT94373A (pt) 1991-02-08
NZ234009A (en) 1993-02-25
DK0403249T3 (da) 1994-05-24

Similar Documents

Publication Publication Date Title
IL85988A0 (en) 1-phenyl-3-naphthalenyloxy-propanamines
AU645253B2 (en) Leukotriene antagonists
HUT47242A (en) Process for producing phenylthio or benzopyranthio derivatives with leukotriene-antagonist effect and pharmaceuticals comprising same
AU1114492A (en) Nmda antagonists
JPS6426571A (en) Leukotriene antagonist
EP0403250A3 (en) Phenylglycidamides useful for preparing alpha-hydroxy-beta-sulfido-arylpropionic acid derivatives
IE882107L (en) Pyrimidones
ZA916013B (en) Process and intermediate for the preparation of 2-hydroxy-3-sulfido-3-phenyl propanoic acids
IE902230L (en) Bis(benzylpyrrolidine) derivatives
ATE63310T1 (de) Herstellung von thienoimidazolderivaten.
GR3034656T3 (en) Anellated dihydropyridines and their use in the production of pharmaceutical preparations
JPS57200372A (en) Novel 5-substituted-2-((n-morpholino)-n-nitrosoamino- methyl)oxadiazole derivative and preventing agent for thrombosis containing the same as principal constituent
TH13534EX (th) กรรมวิธีและอินเทอร์มิเดียทสำหรับเตรียม 2-ซับสทิทิวเทดเบนแซลดิไฮด์